Rayzebio Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Rayzebio Inc in the third quarter 2023?
Rayzebio Inc achieved a return on average equity (ROE) of 324.65 % in its third quarter 2023, this is above RYZB's average return on equity of 0%.
Rayzebio Inc shareholder's equity over the 12 months ending in its third quarter 2023 are valued at $116 million

While the company's net income was fading, Rayzebio Inc was able to improve its ROE compared to the third quarter 2022.

Within the Major Pharmaceutical Preparations industry Rayzebio Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the third quarter 2022 at no. .

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2023) III. Quarter	(Sep 30 2022) III. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	377	395	0	0	0
Return On Equity (TTM)	324.65 %	-	-	-	-
RYZB's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	575	-111	0	0	0
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to RYZB Management Effectiveness >> RYZB's 5 Years Annual ROE >> Compare RYZB ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

RYZB Annual Return On Equity
Total Equity in Millions	0	0	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

Back to RYZB Management Effectiveness >> RYZB's 5 Years Annual ROE >> Compare RYZB ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RYZB's' Return on Equity at Yahoo Finance
RYZB's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RYZB's Competitors
Subscribers only: Roe for Rayzebio Inc 's Suppliers
Subscribers only: Return On Equity for RYZB's Customers

Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector	ROE
Ir med Inc	304.20 %
Tff Pharmaceuticals Inc	242.93 %
Therapeuticsmd Inc	216.13 %
Scynexis Inc	182.33 %
Biomx Inc	173.61 %
Halozyme Therapeutics Inc	159.73 %
Inhibitor Therapeutics Inc	141.82 %
Amgen Inc	129.08 %
Waters Corporation	119.99 %
Glucotrack Inc	93.47 %
Lite Strategy Inc	87.24 %
Idexx Laboratories Inc	85.68 %
Dariohealth Corp	76.80 %
Davita Inc	76.14 %
Medpace Holdings Inc	68.48 %
Opus Genetics Inc	65.54 %

Date modified: 2026-09-26T07:42:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.